Showing 8601-8610 of 19295 results for "".
- New AI Tool Accurately Detects 6 Different Cancer Types on Whole-Body PET/CT Scanshttps://reachmd.com/news/new-ai-tool-accurately-detects-6-different-cancer-types-on-whole-body-petct-scans/2467008/June 10, 2024 Toronto, Ontario—A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By automatically q
- Could a Common Diabetes Drug Ease Knee Osteoarthritis Pain—and Delay Surgery?https://reachmd.com/news/drug-repurposing-diabetes-medication-for-managing-knee-osteoarthritis-pain/2474341/In an era where repurposing familiar drugs has become a promising frontier in medicine, metformin—a stalwart in type 2 diabetes care—is stepping into an unexpected new role. Recent clinical trials suggest that this decades-old medication may significantly reduce kn
- Integrating Social Determinants and Therapeutic Innovations in Diabetes Managementhttps://reachmd.com/news/integrating-social-determinants-and-therapeutic-innovations-in-diabetes-management/2476032/Diabetes management is as much about understanding social contexts as it is about leveraging the latest medical advancements. Unpacking these layers is critical in shaping effective and equitable healthcare strategies. Social determinants like neighborhood deprivation exert a measura
- Diabetes Prevention and Education: Lifestyle Interventions in Focushttps://reachmd.com/news/diabetes-prevention-and-education-lifestyle-interventions-in-focus/2474367/With rising rates of diabetes, prediabetes, and obesity, healthcare professionals are leveraging educational programs that combine nutritional guidance with structured physical activity to halt disease progression and empower patients. Overview
- GLP-1 Receptor Agonists Linked to Lower Risk of Early-Onset Colorectal Cancer in Diabetic Patientshttps://reachmd.com/news/glp-1-receptor-agonists-linked-to-lower-risk-of-early-onset-colorectal-cancer-in-diabetic-patients/2468569/In a promising development for cancer prevention, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), commonly used in diabetes management, have been linked to a reduced risk of early-onset colorectal cancer (EO-CRC) in patients under 50 with type 2 diabetes. These findings, presented at the r
- Cleveland Clinic Study Shows Bariatric Surgery Outperforms GLP-1 Diabetes Drugs for Kidney Protectionhttps://reachmd.com/news/cleveland-clinic-study-shows-bariatric-surgery-outperforms-glp-1-diabetes-drugs-for-kidney-protection/2468276/A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was
- The Role of Gut-Derived Metabolites in Diabetes and Liver Healthhttps://reachmd.com/news/the-role-of-gut-derived-metabolites-in-diabetes-and-liver-health/2475934/Understanding how gut-derived metabolites impact blood sugar regulation and liver health is at the forefront of innovative diabetes management. As diabetes prevalence climbs, clinicians face mounting complexity in tailoring metabolic control. Emerging research highlights that microbi
- Advancing Diabetes Risk Prediction through the CRP-Triglyceride Glucose Indexhttps://reachmd.com/news/biomarker-innovation-advancing-diabetes-risk-prediction-through-the-crp-triglyceride-glucose-index/2485036/Cumulative exposure to the c-reactive protein-triglyceride glucose index (CTI) predicts higher incident diabetes risk in middle-aged and older adults, suggesting a readily ob
- Evaluating the TyG Index in Diabetes Prediction for COVID-19 Patientshttps://reachmd.com/news/evaluating-the-tyg-index-in-diabetes-prediction-for-covid-19-patients/2484252/A new cross-sectional pilot shows the triglyceride–glucose (TyG) index strongly associates with newly diagnosed diabetes among patients hospitalized with moderate–severe COVID-19, and the association is amplified when combined with BMI;
- Managing Myopia and Monitoring Ocular Risks: Insights for Pediatric and Diabetic Carehttps://reachmd.com/news/managing-myopia-and-monitoring-ocular-risks-insights-for-pediatric-and-diabetic-care/2483457/Clinicians are increasingly balancing the promise of interventions that preserve vision—from childhood myopia control to metabolic therapies in diabetes—against the need for vigilant ocular monitoring. Comparative efficacy—measured by axial length elongation and sphe